(CIDRAP News) The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.
(CIDRAP News) European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.
(CIDRAP News) In an update on H1N1 influenza activity, the World Health Organization (WHO) said today that 168 countries and territories on all continents have now had cases and that the new virus increasingly dominates the flu landscape.
(CIDRAP News) Flu activity is increasing in many of the Northern Hemisphere's temperate-zone countries, with influenza B cocirculating with the 2009 pandemic H1N1 virus across Europe and teaming up with influenza A (H3N2) in the United States and Canada, the World Health Organization (WHO) said in its latest update.
(CIDRAP News) Influenza activity in the United States last week increased in intensity and extent, sending more people to doctor's offices, the US Centers for Disease Control and Prevention (CDC) said today.